Infinity BiologiX completed the acquisition of Roylance Pharma.

Infinity BiologiX, a sample collection, processing and storage provider, completed the acquisition of Roylance Pharma, a company specializing in biospecimen storage. Financial terms were not disclosed. “We are excited to welcome the Roylance Pharma team into the IBX family. Combining our two great organisations serves to strengthen the support we provide our clients whilst accelerating our already impressive growth on an international scale,” Robin Grimwood, Infinity BiologiX CEO.